RIO DE JANEIRO, BRAZIL - After reporting that it has made progress in developing a vaccine against the coronavirus, Johnson & Johnson's shares recorded gains of nine percent during Monday's regular trading session on the New York Stock Exchange (NYSE).
The shares of the world's largest health care company are trading above US$133 after the company released a statement reporting progress in studies of an experimental vaccine for the Covid-19, which could be ready for emergency use by 2021.
J&J said it will start clinical trials of the vaccine in humans by September. This . . .